A novel, rapid and sensitive analytical method is described for determination of ofloxacin and levofloxacin by enhanced chemiluminescence (CL) with flow-injection sampling.
Ofloxacin [OFLX, (±)9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7-H-pyrido(1,2,3-de)-1,4-benzoxazine-6-carboxylic acid] is one of the third generation members of quinolone synthetic antibiotics. It exhibits a broad spectrum of activity against gram-positive and gram-negative bacterial through inhibition of their DNA gyrase. 1, 2 Ofloxacin is a chiral compound, and levofloxacin is the active (-) S isomer. OFLX and levofloxacin (LOFLX) were widely used in the treatment of respiratory tract and urinary tract infections. Quality control of OFLX and LOFLX dosage and their monitoring in biological fluids by quick automated techniques are important analytical tasks.
A variety of techniques have been reported for the determination of fluoroquinolones either in pure, dosage or in biological fluids. Among them, HPLC has been utilized extensively for the determination of OFLX 3, 4 and LOFLX. [5] [6] [7] Carlucci presented a review of the published HPLC assays with UV or fluorescence detection for individual fluoroquinolones. 8 The chemiluminescence (CL) method shows the advantages of simplicity, rapidity and high sensitivity, and has been studied extensively for the analysis of pharmaceutical compounds. A critical review was presented about the use of acidic solutions of potassium permanganate to generate chemiluminescence during the oxidation of both organic compounds and inorganic species. 9 CL methods for the determination of ofloxacin were reviewed. 10 Sodium sulfite is a classical reductant and has been used with potassium permanganate to detect some pharmaceutical compounds, but the CL that resulted from the redox reaction of potassium permanganate with sodium sulfite has relatively low sensitivity. 11, 12 The use of potassium permanganate-sodium sulfite CL detection was described for the determination of enoxacin and ofloxacin in dosage form and urine sample with a detection limit of 5.6 × 10 -10 mol l -1 for OFLX. 13 A CL flow-injection method based on the CL reaction of cerium(IV)-sulfiteofloxacin was proposed for the determination of ofloxacin in pharmaceuticals with a detection limit of 1.6 × 10 -5 g ml -1 and 4 × 10 -8 mol l -1 . 14, 15 Based on the CL reaction of the fluoroquinolones with tris(2,2′-bipyridyl)ruthenium(II) and Ce(IV) in sulfuric acid medium, a CL method has been described for the determination of ofloxacin, norfloxacin and ciprofloxacin hydrochloride in dosage forms and biological fluids with a detection limit of 5.5 × 10 -9 mol l -1 ofloxacin. 16 A CL flow-through sensor based on the sensitizing effect of ofloxacin on the CL oxidation of sulfite by PbO2 in H2SO4 media was described for determination of ofloxacin in pharmaceutical preparations with a detection limit of 7.8 × 10 -8 g ml -1 . 17 The use of hydrogen peroxide as oxidant for sodium nitrite-sulfuric acid system was described for the determination of ciprofloxacin, norfloxacin and ofloxacin in pharmaceutical preparations by enhancement of weak CL from peroxynitrous acid with a detection limit of 1.1 × 10 -7 mol l -1 ofloxacin. 18 But the CL method for the determinations of LOFLX has seldom been reported. An Eu(III) sensitized CL-Ce(IV)-sulfite system has been applied for determination of levofloxacin, moxifloxacin and trovafloxacin in pharmaceutical preparations with a detection limit of 0.100 mg ml -1 for LOFLX. 19 A LOFLX-sensitized CL luminol-H2O2 system has been used for determination of LOFLX in capsule samples, with a detection limit of 1.38 × 10 -11 mol l -1 . 20 In this work, the authors found that CL signals of Ce(IV)-OFLX/LOFLX in acidic medium could be enhanced by sodium hyposulfite. The CL intensity was correlated linearly with the concentration of OFLX in the ranges of 1.0 × 10 -8 -1.0 × 10 -7 g ml -1 and 1.0 × 10 -7 -6.0 × 10 -6 g ml -1 . This CL method combined with flow injection technique has been applied for the determination of OFLX and LOFLX in pharmaceutical preparations and biological fluids with satisfactory results.
Experimental

Apparatus
A MPI-B-FI-CL analysis system (Xi'an Remex Electronic Science-Tech Co. Ltd., Xi'an, China) was used in the CL detection. It consists of two peristaltic pumps working at a constant flow rate (30 rpm) and a six-way injection valve with a sample loop (120 μl), which is automatically operated by a computer equipped with a program for control of MPI-B flow injection analysis. PTFE tubing (0.8 mm i.d.) was used to connect all components in the flow system. The flow cell is a twisted glass tube in order to produce a large surface area exposed to the adjacent photomultiplier tube (PMT, Hamamatsu, Japan). The signal from the CL reaction was recorded by an analyzer. UV spectra were measured with an UV-265 spectrophotometer (Shimadzu, Japan). Fluorescence spectra were recorded with an RF-5301PC spectrofluorometer (Shimadzu, Japan). The detector (Model MPI-B) of flowinjection CL was purchased from Ruimai Company in Xian (China).
Chemicals
All solutions were prepared from analytical grade reagents. Water was purified with an XGJ-30 water purified system purchased from Yongsheng Company in Beijing. Stock standard solutions of OFLX (1 × 10 -3 g ml -1 ) and LOFLX (1 × 10 -3 g ml -1 ) were prepared by dissolving 0.0500 g OFLX or LOFLX (Institute of Medicinal Biotechnology, Beijing, China) in 0.005 mol l -1 sulfuric acid, and diluting to 50 ml with the same acid, respectively. The solution should be stored in the dark at 4˚C. The working solutions were prepared by appropriate diluting with deionized water. A cerium(IV) solution (1 × 10 -2 mol l -1 ) was prepared by dissolving 0.6686 g (NH4)2Ce(NO3)64H2O in 4% (v/v) sulfuric acid and diluting to 100 ml. A sodium hyposulfite solution was prepared by dissolving sodium hyposulfite in deionized water. The sulfuric acid (0.06 mol l -1 ) was directly diluted with sulfuric acid. The tablets were provided by Baiyunshan Pharmaceuticals Ltd. Co. (Guangzhou, China) and Datong Yunhua Pharmaceuticals Ltd. Co. (Shanxi, China), and CPFX injections were provided by Kelun Pharmaceuticals Ltd. Co. (Sichuan, China).
Sample preparation
Sample solutions for analysis were prepared as follows. The average tablet weights were calculated from the weight of 10 tablets which were selected from the same group randomly. An accurately weighed portion of each homogenized sample containing 100 mg of OFLX or LOFLX was dissolved with deionized water and diluted to 100 ml, respectively. The working solutions were prepared by appropriate dilutions so that the final concentration was in the linear range.
The sample of OFLX was confected by mixing five bottles of the injections selected randomly from same group. The working solution was directly diluted with deionized water. The injection sample of LOFLX was made in the same way as OFLX.
A 1 ml volume of serum sample provided by healthy volunteers was deproteinized by adding 4.0 ml of 10% trichloroacetic acid (CCl3COOH) in a centrifuge tube, which was centrifuged for 15 min at 4000 rpm. The supernatant was diluted with deionized water so as to obtain a concentration of OFLX or LOFLX in the range of linearity previously determined. No further pretreatment was required for urine samples.
Procedure
The flow-injection CL analyzer system is shown in Fig. 1 . Because there is no reaction between Ce(IV) solution and H2SO4 solution, they were merged previously and used as the carrying fluid. The mixture was delivered through a three-way pipe into a flow cell by a peristaltic pump. Then sample and sodium hyposulfite solutions were delivered into the carrier steam at a six ways valve through another peristaltic pump at equal flow rate. When the mixed solution flowed into the cell, the CL reaction took place. The CL emission signal produced in the cell was recorded by the analyzer. Calibration graphs were constructed by plotting the intensity (peak height) of the CL signal versus the concentration of OFLX or LOFLX.
Results and Discussion
Choice of CL system
An attempt was made to examine if there is any oxidant that could be applied to the CL determination of OFLX or LOFLX. The results indicated that no significant CL signal could be observed upon the reactions of KMnO4 and Na2S2O3, Na2SO3, Na2S2O4, or H2O2 in acidic medium in the presence of OFLX or LOFLX, moreover, no significant CL signal was found upon the reactions of Ce(IV) and HCHO, H2O2, or Rodam B in acidic medium in the presence of OFLX or LOFLX. However, the KMnO4-HCHO, Ce(IV)-Na2SO3 and Ce(IV)-Na2S2O3 systems in the presence of OFLX or LOFLX could each produce a CL signal in acidic medium, respectively. Further investigation found that the maximum CL signal was observed by using Na2S2O4 instead of Na2SO3 or Na2S2O3 for Ce(IV)-OFLX/LOFLX system in acidic medium. So this system was used throughout for subsequent work. A series of experimental conditions were investigated and optimized for the maximum CL emission of Ce(IV)-NaS2O4-OFLX/LOFLX.
Effect of sodium hyposulfite concentration
In this CL system, the concentration of Na2S2O4 used as a reductant not only had an effect on the sensitivity, but also influenced the linear range for the assay. The effects of sodium hyposulfite concentration in the range of 1 × 10 -5 -1 × 10 -3 mol l -1 on the CL emission of 1 μg ml -1 OFLX or LOFLX were examined under Ce(IV) concentration of 0.5 mmol l -1 in 0.06 mol l -1 sulfuric acid medium. The maximum CL emission was observed upon usage of 5 × 10 -4 mol l -1 sodium hyposulfite solution.
Effect of Ce(IV) concentration
The effects of Ce(IV) concentration in the range of 5 × 10 -5 -1 × 10 -3 mol l -1 on the CL emission intensity of 1 μg ml -1 OFLX
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ANALYTICAL SCIENCES AUGUST 2006, VOL. 22 or LOFLX in 0.07 mol l -1 sulfuric acid medium were studied with 0.5 mmol l -1 hyposulfite sodium. The CL emission intensity increased observably with the increase of Ce(IV) concentration in the range from 0.25 mmol l -1 to 0.5 mmol l -1 , and decreased remarkably beyond 0.5 mmol l -1 . Maximum emission was obtained upon usage of 5 × 10 -4 mol l -1 Ce(IV) solution. This concentration was used throughout for subsequent work.
Choice of the inorganic acids
The kind and concentration of the acid used in the reaction has a very significant influence on the CL emission intensity. Ce(IV) salt can not be dissolved in water. Therefore, several kinds of acids, such as HCl, HNO3, H3PO4 and H2SO4, were added to the Ce(IV) solution to test the effect on the CL signal of OFLX or LOFLX (1 μg ml -1 ). According to the experimental result, sulfuric acid was selected because it gave the best CL signal. The effect of sulfuric acid concentration on CL signal was tested over the range of 0.02 -0.08 mol l -1 . The maximum CL intensity was obtained at 0.07 mol l -1 sulfuric acid concentration, which was selected for subsequent experiments.
Effect of sample volume and flow rate
The sample volume and flow rate are critical. The CL maximum emission could not be obtained if the sample volume is too small or too large. The highest emission was produced if the injected sample volume was 120 μl. The CL intensity increased with increasing flow rate. However, a flow rate of 3.0 ml min -1 for all solutions is recommended because of greater precision and better economy in the use of reagents.
Possible mechanism
The reaction of Ce(IV) with SO3 2-in acidic medium has been studied in detail. Ce(IV)-SO3 2-CL reaction has a low quantum efficiency and shows weak luminescence. Excited sulfur dioxide has been proposed as the emitting species during the oxidation of sulfite. The possible mechanism of the CL reaction may be to oxidize HSO3 -by Ce(IV) to a hydrogen-sulfite radical HSO3 · , then two HSO3 · radicals react to produce S2O6 2-, in the end, S2O6 2-will result in the excited intermediate product SO2 · . When SO2 · relaxes to its ground state, a photon was emitted. 21 The excited state SO2 · emits radiation in the spectral region of 300 -450 nm. 22 Na2S2O4 in acidic medium can react to produce HSO3 -. The possible mechanism of the CL reaction of Ce(IV)-S2O4 2-may include product SO2 · . In order to obtain more information about the enhanced CL mechanism, we examined the fluorescence spectra. The fluorescence emission spectra of OFLX and Ce(IV)-OFLX are shown in Fig. 2A .
The native fluorescence emission of OFLX shows a broad peak at 503 nm. When mixing with Ce(IV), the fluorescence emission shows a broad peak at 443 nm. It may be the oxide of OFLX. When mixing with Ce(IV), OFLX, and Na2S2O4 occurs in H2SO4 medium, the fluorescence emission shows two broad peaks, with centers at 359 nm and 443 nm. They are similar to the fluorescence emission spectra of SO2 and the oxide of OFLX. The fluorescence emission shows a broad peak at 359 nm for Ce(IV)-Na2S2O4-H2SO4 system. This peak may be produced by SO2 · .
In order to get an idea about the reaction product generating the CL, we examined the CL spectrum of the reaction by a series of interference filters. The CL spectra of cerium(IV)-sodium hyposulfite-sulfuric acid solution in the absence and presence of OFLX were also recorded in the range of 300 -655 nm.
As shown in Fig. 2B , the CL spectra for Ce(IV)-OFLXNa2S2O4-H2SO4 systems show two bands at 353 nm and 506 nm. The emission spectrum at 353 nm is produced by the reaction product SO2 · , otherwise, the energy of the partly excited SO2 · is transferred to OFLX and the emission spectrum at 506 nm is produced by excited OFLX. Therefore, the CL spectra for Ce(IV)-OFLX-Na2S2O4-HNO3 system show the two broad peaks. The same phenomenon (including CL kinetic response curve, CL and fluorescence spectra) was also found when OFLX was replaced by LOFLX. A possible CL mechanism for this system can be described as follows: .
Interference studies
The effects of some common excipients in drugs, of metal ions in human body and of several organic compounds on the CL intensity were investigated for the determination of 4 × 10 -7 g ml -1 OFLX/LOFLX by comparing with CL emissions obtained using OFLX or LEVX solution alone or OFLX/LOFLX with foreign species added. Tolerance was defined as the amount of foreign species that produced an error not exceeding ±5% in the determination of OFLX or LOFLX. The results are listed in Table 1 . Most ions have no influence but Br -, I -and Fe 2+ . If the interference components were existed in real samples, by using the standard addition method the interferences would be eliminated. Since the serum sample has higher concentration of these proteins than the urine sample and thus trichloroacetic acid should be added to each serum sample to remove the proteins mentioned above before determination. However, dilution could minimize the interference in measurement of the urine samples, because these species become fewer when the sample is diluted.
Analytical characteristics
Under the optimum conditions described above, the linearity for determination of OFLX was investigated in the range of 2.0 × 10 -8 -6.0 × 10 -6 g ml -1 . The calibration graph for OFLX and LOFLX consisted of two parts in order to improve the veracity. The regression equation was I = 1.85C -1.00 in the range 2.0 × 10 -8 -1.0 × 10 -7 g ml -1 (r = 0.9988) and I = 14.73C + 38.32 in the range 1.0 × 10 -7 -6.0 × 10 -6 g ml -1 (r = 0.9988). The relative standard derivation (RSD, n = 11) is 2.0% for OFLX at 4 × 10 -7 g ml -1 and for LOFLX at 6 × 10 -7 g ml -1 . The detection limit (S/N = 3) of OFLX and LOFLX for the regression equation I = 1.85C -1.00 is 7 × 10 -9 g ml -1 (1.9 × 10 -8 mol l -1 ). It is much lower than that of other CL methods described in the literature.
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Analysis of pharmaceutical preparations
After each tablet sample was dissolved with water, a known amount of OFLX was added in the sample solution, the mixture was then filtered. The test solution added with OFLX was used to determine recovery. The recovery values for OFLX and LOFLX were in the range of 97.4 -102.4%. The proposed method and the UV-method described in the reference 23 were applied to the determination of OFLX and LOFLX in two pharmaceutical preparations. The results are given in Table 2 , along with labeled contents. The results obtained by the proposed method agree with the labeled contents. Statistical analysis of the results using Student t-test and the variance ratio F-test showed no significant difference at p = 0.05 between the performance of the two methods as regards to accuracy and precision.
Analysis of urine samples
The OFLX and LOFLX are readily absorbed after oral ingestion and a peak urine concentration occurs in approximately 2 -4 h. 24 One healthy volunteer took orally 200 mg of OFLX tablets, and his urine samples within 0 -12 h were gathered. At the same time, another volunteer took 200 mg of LOFLX tablets, and his urine samples within 0 -12 h were gathered, too. In order to make the sample concentrations of the drug within the linear range of determination, we diluted the urine samples properly and analyzed them by the standard addition method. For every urine sample with OFLX gathered in the interval time, the recovery was investigated. The results for the content and recovery of OFLX and LOFLX are summarized in Table 3 .
Analysis of spiked serum sample
It was reported that the maximum concentration of OFLX in the serum was 3.48 ± 0.77 μg ml -1 after an oral administration of 400 mg of OFLX, but the maximum concentration of LOFLX in the serum was 0.57 -2.04 μg ml -1 after an oral administration of 50 -200 mg of LOFLX. 25 In order to make the sample concentration of the drug within the linear range of determination, we diluted the serum sample appropriately. The standard addition method was used to avoid matrix effects. The results obtained are given in Table 4 .
In this paper, a new flow-injection CL method for determination of OFLX and LOFLX is described based on the reaction of Ce(IV)-hyposulfite-analyte in acid medium.
From the experimental point of view, the manipulation is very simple, and sequential measurement was permitted with high sample frequency, up to 60 samples per hour. The proposed CL method used cheaper instruments and reagents than those of spectrophotometry, fluorometry, HPLC and other CL method with terbium(III) and europium(III) as enhancers. As compared with other CL methods described in the literature, [14] [15] [16] [17] [18] [19] the proposed method has higher sensitivity. The proposed flowinjection CL method can be used for routine determination of OFLX and LOFLX in pharmaceutical preparations and biological fluids. Recovery, % RSD, % (n = 5)
